Popular topics to explore

★All TopicsEquity ResearchFundamental ViewsHidden GemsIndex StrategiesIPOMacro ViewsMiscellaneousPersonal FinancePost-Closing CommentaryPre-Opening CommentaryPsychology of MoneySector BreakoutStock In NewsTechnical ViewsTime To ExitToday's Trading SetupTrending SectorsWatch Out For
‹ All Posts
Shaly Gupta
Shaly Gupta

6th Mar 2025 · SEBI-Registered Analyst

ZYDUS

*Zydus Lifesciences:* Company secures USFDA approval to sell generic leukaemia tablets

ZYDUSLIFE

#Today’sTradingSetup#StockInNews#TechnicalViews
ZYDUSLIFE_2025-03-05_20-29-07.png
122 likes·67 comments